Nie Z, Chang J, Yang Z, Zeng K, Liu Y, Tu Q
Cancer Immunol Immunother. 2025; 74(4):139.
PMID: 40056169
PMC: 11890482.
DOI: 10.1007/s00262-025-03981-w.
Mantovani A, Marchesi F, Di Mitri D, Garlanda C
Cell Mol Immunol. 2024; 21(11):1201-1214.
PMID: 39402303
PMC: 11528009.
DOI: 10.1038/s41423-024-01216-z.
Ma C, Hao Y, Shi B, Wu Z, Jin D, Yu X
Cancer Gene Ther. 2024; 31(7):1034-1048.
PMID: 38806621
DOI: 10.1038/s41417-024-00788-2.
Di Ceglie I, Carnevale S, Rigatelli A, Grieco G, Molisso P, Jaillon S
Front Immunol. 2024; 15:1341390.
PMID: 38426089
PMC: 10903099.
DOI: 10.3389/fimmu.2024.1341390.
Singhal S, Rao A, Stadanlick J, Bruns K, Sullivan N, Bermudez A
Cancer Res. 2024; 84(7):1029-1047.
PMID: 38270915
PMC: 10982649.
DOI: 10.1158/0008-5472.CAN-23-2135.
Immunotherapy and biomarkers in patients with lung cancer with tuberculosis: Recent advances and future Directions.
Yang L, Zhuang L, Ye Z, Li L, Guan J, Gong W
iScience. 2023; 26(10):107881.
PMID: 37841590
PMC: 10570004.
DOI: 10.1016/j.isci.2023.107881.
Functional crosstalk and regulation of natural killer cells in tumor microenvironment: Significance and potential therapeutic strategies.
Wang L, Chen Z, Liu G, Pan Y
Genes Dis. 2023; 10(3):990-1004.
PMID: 37396514
PMC: 10308134.
DOI: 10.1016/j.gendis.2022.07.009.
Organogermanium THGP Induces Differentiation into M1 Macrophages and Suppresses the Proliferation of Melanoma Cells via Phagocytosis.
Azumi J, Takeda T, Shimada Y, Zhuang T, Tokuji Y, Sakamoto N
Int J Mol Sci. 2023; 24(3).
PMID: 36768216
PMC: 9915250.
DOI: 10.3390/ijms24031885.
Improved Antitumor Effect of NK Cells Activated by Neutrophils in a Bone Marrow Transplant Model.
Nakato D, Iwamoto S, Amano K, Ito T, Toyoda H, Hanaki R
Mediators Inflamm. 2023; 2023:6316581.
PMID: 36762286
PMC: 9904906.
DOI: 10.1155/2023/6316581.
No NETs no TIME: Crosstalk between neutrophil extracellular traps and the tumor immune microenvironment.
Fang Q, Stehr A, Naschberger E, Knopf J, Herrmann M, Sturzl M
Front Immunol. 2023; 13:1075260.
PMID: 36618417
PMC: 9816414.
DOI: 10.3389/fimmu.2022.1075260.
Exploring the Utility of NK Cells in COVID-19.
Deng X, Terunuma H, Nieda M
Biomedicines. 2022; 10(5).
PMID: 35625739
PMC: 9138257.
DOI: 10.3390/biomedicines10051002.
Central nervous system immune interactome is a function of cancer lineage, tumor microenvironment, and STAT3 expression.
Najem H, Ott M, Kassab C, Rao A, Rao G, Marisetty A
JCI Insight. 2022; 7(9).
PMID: 35316217
PMC: 9090258.
DOI: 10.1172/jci.insight.157612.
Neutrophil and Natural Killer Cell Interactions in Cancers: Dangerous Liaisons Instructing Immunosuppression and Angiogenesis.
Palano M, Gallazzi M, Cucchiara M, De Lerma Barbaro A, Gallo D, Bassani B
Vaccines (Basel). 2021; 9(12).
PMID: 34960234
PMC: 8709224.
DOI: 10.3390/vaccines9121488.
Metabolic Rewiring in the Tumor Microenvironment to Support Immunotherapy: A Focus on Neutrophils, Polymorphonuclear Myeloid-Derived Suppressor Cells and Natural Killer Cells.
De Lerma Barbaro A, Palano M, Cucchiara M, Gallazzi M, Mortara L, Bruno A
Vaccines (Basel). 2021; 9(10).
PMID: 34696286
PMC: 8539473.
DOI: 10.3390/vaccines9101178.
Remodeling the Tumor Myeloid Landscape to Enhance Antitumor Antibody Immunotherapies.
Hussain K, Cragg M, Beers S
Cancers (Basel). 2021; 13(19).
PMID: 34638388
PMC: 8507767.
DOI: 10.3390/cancers13194904.
Biocompatibility Evolves: Phenomenology to Toxicology to Regeneration.
Crawford L, Wyatt M, Bryers J, Ratner B
Adv Healthc Mater. 2021; 10(11):e2002153.
PMID: 33829678
PMC: 8221530.
DOI: 10.1002/adhm.202002153.
Human NK cells: From development to effector functions.
Perera Molligoda Arachchige A
Innate Immun. 2021; 27(3):212-229.
PMID: 33761782
PMC: 8054151.
DOI: 10.1177/17534259211001512.
Short-term IL-15 priming leaves a long-lasting signalling imprint in mouse NK cells independently of a metabolic switch.
Luu T, Schmied L, Nguyen N, Wiel C, Meinke S, Mohammad D
Life Sci Alliance. 2021; 4(4).
PMID: 33593878
PMC: 7918643.
DOI: 10.26508/lsa.202000723.
Tumor-associated myeloid cells: diversity and therapeutic targeting.
Mantovani A, Marchesi F, Jaillon S, Garlanda C, Allavena P
Cell Mol Immunol. 2021; 18(3):566-578.
PMID: 33473192
PMC: 8027665.
DOI: 10.1038/s41423-020-00613-4.
NK cells: A double edge sword against SARS-CoV-2.
Masselli E, Vaccarezza M, Carubbi C, Pozzi G, Presta V, Mirandola P
Adv Biol Regul. 2020; 77:100737.
PMID: 32773100
PMC: 7292949.
DOI: 10.1016/j.jbior.2020.100737.